Ali Keshavarzian to Cyclic Nucleotide Phosphodiesterases, Type 4
This is a "connection" page, showing publications Ali Keshavarzian has written about Cyclic Nucleotide Phosphodiesterases, Type 4.
Connection Strength
0.087
-
Phosphodiesterase 4 inhibitors and inflammatory bowel disease: emerging therapies in inflammatory bowel disease. Expert Opin Investig Drugs. 2007 Sep; 16(9):1489-506.
Score: 0.071
-
A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis. Gastroenterology. 2007 Jan; 132(1):76-86.
Score: 0.017